Downregulation of Reelin Predicts Poor Prognosis for Glioma

References

• Maugeri R , SchieraG, DiLiegro CM, FricanoA, IacopinoDG, DiLiegro I. Aquaporins and brain tumors. Int. J. Mol. Sci.17(7), 1029 (2016).
   PubMed Web of Science ®Google Scholar
• Ameratunga M , PavlakisN, WheelerH, GrantR, SimesJ, KhasrawM. Anti-angiogenic therapy for high-grade glioma. Cochrane Database Syst. Rev.11(9), CD008218 (2018).
   PubMedGoogle Scholar
• Maachani UB , ShankavaramU, KrampT, TofilonPJ, CamphausenK, TandleAT. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells. Oncotarget7(47), 77365–77377 (2016).
   PubMedGoogle Scholar
• Gupta K , SalunkeP. Molecular markers of glioma: an update on recent progress and perspectives. J. Cancer Res. Clin. Oncol.138(12), 1971–1981 (2012).
   PubMed Web of Science ®Google Scholar
• Forster E , JossinY, ZhaoS, ChaiX, FrotscherM, GoffinetAM. Recent progress in understanding the role of reelin in radial neuronal migration, with specific emphasis on the dentate gyrus. Eur. J. Neurosci.23(4), 901–909 (2006).
   PubMed Web of Science ®Google Scholar
• Hiesberger T , TrommsdorffM, HowellBWet al. Direct binding of reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron24(2), 481–489 (1999).
   PubMed Web of Science ®Google Scholar
• Lacor PN , GraysonDR, AutaJ, SugayaI, CostaE, GuidottiA. Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. Proc. Natl Acad. Sci. USA97(7), 3556–3561 (2000).
   PubMed Web of Science ®Google Scholar
• Morimura T , HattoriM, OgawaM, MikoshibaK. Disabled-1 regulates the intracellular trafficking of reelin receptors. J. Biol. Chem.280(17), 16901–16908 (2005).
   PubMed Web of Science ®Google Scholar
• Jossin Y , OgawaM, MetinC, TissirF, GoffinetAM. Inhibition of Src family kinases and non-classical protein kinases C induce a reeler-like malformation of cortical plate development (vol 23, pg 9953, 2003). J. Neurosci.25(26), 6260 (2005).
   Web of Science ®Google Scholar
• Niu S , RenfroA, QuattrocchiCC, SheldonM, D'arcangeloG. Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron.41(1), 71–84 (2004).
   PubMed Web of Science ®Google Scholar
• Arnaud L , BallifBA, ForsterE, CooperJA. Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. Curr. Biol.13(1), 9–17 (2003).
   PubMed Web of Science ®Google Scholar
• Lakoma J , Garcia-AlonsoL, LuqueJM. Reelin sets the pace of neocortical neurogenesis. Development138(23), 5223–5234 (2011).
   PubMed Web of Science ®Google Scholar
• Dulabon L , OlsonEC, TaglientiMGet al. Reelin binds alpha3beta1 integrin and inhibits neuronal migration. Neuron27(1), 33–44 (2000).
   PubMed Web of Science ®Google Scholar
• Sekine K , KawauchiT, KuboKet al. Reelin controls neuronal positioning by promoting cell-matrix adhesion via inside-out activation of integrin alpha5beta1. Neuron76(2), 353–369 (2012).
   PubMed Web of Science ®Google Scholar
• Chai XJ , ForsterE, ZhaoST, BockHH, FrotscherM. Reelin stabilizes the actin cytoskeleton of neuronal processes by inducing n-cofilin phosphorylation at serine3. J. Neurosci.29(1), 288–299 (2009).
   PubMed Web of Science ®Google Scholar
• Nagai S , MorenoO, SmithCAet al. Role of the cofilin activity cycle in astrocytoma migration and invasion. Genes Cancer2(9), 859–869 (2011).
   PubMedGoogle Scholar
• Khialeeva E , ChouJW, AllenDE, ChiuAM, BensingerSJ, CarpenterEM. Reelin deficiency delays mammary tumor growth and metastatic progression. J. Mammary Gland Biol. Neoplasia22(1), 59–69 (2017).
   PubMed Web of Science ®Google Scholar
• Honda T , KobayashiK, MikoshibaK, NakajimaK. Regulation of cortical neuron migration by the reelin signaling pathway. Neurochem. Res.36(7), 1270–1279 (2011).
   PubMed Web of Science ®Google Scholar
• Sato N , FukushimaN, ChangR, MatsubayashiH, GogginsM. Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers. Gastroenterology130(2), 548–565 (2006).
   PubMed Web of Science ®Google Scholar
• Smalheiser NR , CostaE, GuidottiAet al. Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia and adrenal chromaffin cells. Proc. Natl Acad. Sci. USA97(3), 1281–1286 (2000).
   PubMed Web of Science ®Google Scholar
• Luo Y , HuangK, ZhengJ, ZhangJ, ZhangL. TGF-beta1 promotes cell migration in hepatocellular carcinoma by suppressing reelin expression. Gene688, 19–25 (2019).
   PubMed Web of Science ®Google Scholar
• Castellano E , Molina-ArcasM, KrygowskaAAet al. RAS signalling through PI3-Kinase controls cell migration via modulation of reelin expression. Nat. Commu.7, 11245 (2016).
   PubMed Web of Science ®Google Scholar
• Schulze M , ViolonchiC, SwobodaSet al. RELN signaling modulates glioblastoma growth and substrate-dependent migration. Brain Pathol.28(5), 695–709 (2018).
   PubMed Web of Science ®Google Scholar
• Friedmann-Morvinski D , BushongEA, KeEet al. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science338(6110), 1080–1084 (2012).
   PubMed Web of Science ®Google Scholar
• Alcantara LS , ChenJ, KwonCHet al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell.15(1), 45–56 (2009).
   PubMed Web of Science ®Google Scholar
• Kwon IS , ChoSK, KimMJet al. Expression of Disabled-1 suppresses astroglial differentiation in neural stem cells. Mol. Cell. Neurosci.40(1), 50–61 (2009).
   PubMed Web of Science ®Google Scholar
• Irizarry RA , HobbsB, CollinFet al. Exploration, normalization and summaries of high density oligonucleotide array probe level data. Biostatistics4(2), 249–264 (2003).
   PubMed Web of Science ®Google Scholar
• Leek JT , MonsenE, DabneyAR, StoreyJD. EDGE: extraction and analysis of differential gene expression. Bioinformatics22(4), 507–508 (2006).
   PubMed Web of Science ®Google Scholar
• Louis DN , PerryA, ReifenbergerGet al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol.131(6), 803–820 (2016).
   PubMed Web of Science ®Google Scholar
• Brat DJ , VerhaakRG, AldapeKDet al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med.372(26), 2481–2498 (2015).
   PubMed Web of Science ®Google Scholar
• Jia L , SongY, SongHet al. Overexpression of high mobility group box 1 (HMGB1) has no correlation with the prognosis in glioma. Biomark. Med.13(10), 851–863 (2019).
   PubMed Web of Science ®Google Scholar
• Dimitrov L , HongCS, YangC, ZhuangZ, HeissJD. New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma. Int. J. Med. Sci.12(3), 201–213 (2015).
   PubMed Web of Science ®Google Scholar
• Philip B , YuDX, SilvisMRet al. Mutant IDH1 promotes glioma formation in vivo. Cell Rep.23(5), 1553–1564 (2018).
   PubMed Web of Science ®Google Scholar
• Ichimura K . Molecular pathogenesis of IDH mutations in gliomas. Brain Tumor Pathol.29(3), 131–139 (2012).
   PubMed Web of Science ®Google Scholar
• Verhaak RG , HoadleyKA, PurdomEet al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell17(1), 98–110 (2010).
   PubMed Web of Science ®Google Scholar
• Moore LD , LeT, FanG. DNA methylation and its basic function. Neuropsychopharmacology38(1), 23–38 (2013).
   PubMed Web of Science ®Google Scholar
• Stein T , CosimoE, YuXZet al. Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. Am. J. Pathol.177(5), 2323–2333 (2010).
   PubMed Web of Science ®Google Scholar
• Dohi O , TakadaH, WakabayashiNet al. Epigenetic silencing of RELN in gastric cancer. Int. J. Oncol.36(1), 85–92 (2010).
   PubMed Web of Science ®Google Scholar
• Hong SM , KellyD, GriffithMet al. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Mod. Pathol.21(12), 1499–1507 (2008).
   PubMed Web of Science ®Google Scholar
• Perrone G , VincenziB, ZagamiMet al. Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade. Mod. Pathol.20(3), 344–351 (2007).
   PubMed Web of Science ®Google Scholar
• Wang Q , LuJY, YangCHet al. CASK and its target gene reelin were co-upregulated in human esophageal carcinoma. Cancer Lett.179(1), 71–77 (2002).
   PubMed Web of Science ®Google Scholar
• Carvajal AE , Serrano-MoralesJM, Vazquez-CarreteroMDet al. Reelin protects from colon pathology by maintaining the intestinal barrier integrity and repressing tumorigenic genes. Biochim. Biophys. Acta Mol. Basis Dis.1863(9), 2126–2134 (2017).
   PubMed Web of Science ®Google Scholar
• Yuan Y , ChenH, MaG, CaoX, LiuZ. Reelin is involved in transforming growth factor-beta1-induced cell migration in esophageal carcinoma cells. PLoS ONE7(2), e31802 (2012).
   PubMed Web of Science ®Google Scholar
• Lin L , YanF, ZhaoDet al. Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin beta1 signaling and STAT3. Oncotarget7(9), 9844–9858 (2016).
   PubMedGoogle Scholar
• Baylin SB , HermanJG, GraffJR, VertinoPM, IssaJP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res.72, 141–196 (1998).
   PubMed Web of Science ®Google Scholar
• Ushijima T , SasakoM. Focus on gastric cancer. Cancer Cell5(2), 121–125 (2004).
   PubMed Web of Science ®Google Scholar
• Desilva U , D'arcangeloG, BradenVVet al. The human reelin gene: isolation, sequencing and mapping on chromosome 7. Genome Res.7(2), 157–164 (1997).
   PubMed Web of Science ®Google Scholar
• Chen Y , SharmaRP, CostaRH, CostaE, GraysonDR. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res.30(13), 2930–2939 (2002).
   PubMed Web of Science ®Google Scholar
• Serrano-Morales JM , Vazquez-CarreteroMD, PeralMJ, IlundainAA, Garcia-MirandaP. Reelin-Dab1 signaling system in human colorectal cancer. Mol. Carcinog.56(2), 712–721 (2017).
   PubMed Web of Science ®Google Scholar
• Liu J , HuaP, HuiL, ZhangLL, HuZ, ZhuYW. Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy. Exp. Ther. Med.12(4), 2109–2119 (2016).
   PubMed Web of Science ®Google Scholar
• Wu DY , PrivesC. Relevance of the p53-MDM2 axis to aging. Cell Death Differ.25(1), 169–179 (2018).
   PubMed Web of Science ®Google Scholar
• Dou A , WangZ, ZhangN, LiuJ. Loss of reelin suppresses cell survival and mobility in non-Hodgkin lymphoma. Oncol. Rep.37(6), 3572–3580 (2017).
   PubMed Web of Science ®Google Scholar
• Jandial R , ChoyC, LevyDM, ChenMY, AnsariKI. Astrocyte-induced reelin expression drives proliferation of Her2(+) breast cancer metastases. Clin. Exp. Metastasis34(2), 185–196 (2017).
   PubMed Web of Science ®Google Scholar
• Venkateswaran N , Conacci-SorrellM. MYC leads the way. Small GTPases11(2), 86–94 (2020).
   PubMedGoogle Scholar
• Viale G , TrapaniD, CuriglianoG. Mismatch repair deficiency as a predictive biomarker for immunotherapy efficacy. Biomed Res. Int.2017, 4719194 (2017).
   PubMed Web of Science ®Google Scholar
• Da Cunha Colombo Bonadio RR , FogaceRN, MirandaVC, DizM. Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management. Clinics (Sao Paulo)73(Suppl. 1), e450s (2018).
   PubMedGoogle Scholar
• Spies M , FishelR. Mismatch repair during homologous and homeologous recombination. Cold Spring Harb. Perspect. Biol.7(3), a022657 (2015).
   PubMed Web of Science ®Google Scholar